The estimation of respiratory muscles (RM) status by echodensitometry in male patients with acute exacerbation of COPD (AECOPD)

A. Makarevich, S. Lemeshevskaj, A. Pochtavcev (Minsk, Belarus)

Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles
Session: Interaction between respiratory and peripheral muscles
Session type: E-Communication Session
Number: 1982
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Makarevich, S. Lemeshevskaj, A. Pochtavcev (Minsk, Belarus). The estimation of respiratory muscles (RM) status by echodensitometry in male patients with acute exacerbation of COPD (AECOPD). Eur Respir J 2010; 36: Suppl. 54, 1982

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The estimation of respiratory muscles (RM) status by echodensitometry in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012


Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 564s
Year: 2002

Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015

Neural respiratory drive (NRD) measured by parasternal electromyography predicts clinical deterioration and early readmission in patients with acute exacerbation of COPD (AECOPD)
Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function
Year: 2014

Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006

Mucociliary clearance (MCC) disorders in patient with acute bronchitis (AB) and acute exacerbation (AE) of COPD and ways of it correction
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Does tolerance of neuro-muscular electrical stimulation (NMES) relate to gender in patients with an acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2012 - Physiotherapy and rehabilitative interventions applied to different populations with respiratory impairment
Year: 2012


The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP)
Source: International Congress 2014 – Clinical presentations
Year: 2014


Time course and recovery of respiratory muscles (RM) strength in acute exacerbation of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005

Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes
Source: International Congress 2015 – Different data in COPD
Year: 2015


Neural respiratory drive (NRD) to predict long term mortality after an acute exacerbation of COPD (AECOPD)
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



Vascular-platelet hemostasis parameters in the stable phase and in acute exacerbation (AE) of COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Formoterol/budesonide (FBC) in the treatment of acute exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 288s
Year: 2003

COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016


Changes of active expiration respiratory muscle (RM) in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Respiratory and skeletal muscle assessment in health and disease
Year: 2011


The effect of an acute exacerbation of COPD (AECOPD) on balance after pulmonary rehabilitation (PR): a prospective study
Source: International Congress 2017 – Assessing the functional status of patients with COPD
Year: 2017



The influence of co-morbidity on the outcome of non-invasive ventilatory support in patients with acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 277s
Year: 2002

The relationship between echodensitometric parameters of respiratory muscles (RM) and indices of body composition (IBC) in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease
Year: 2011


Sex hormones imbalance in patients with acute exacerbation of COPD (AECOPD)
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008